Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion–Positive Sarcomas

Galen Rask(Nationwide Children's Hospital), Emily R. Theisen(University of Utah), Julia Selich‐Anderson(Nationwide Children's Hospital), Ariunaa Bayanjargal(Nationwide Children's Hospital), Cenny Taslim(Nationwide Children's Hospital), Rachel D. Dreher(Nationwide Children's Hospital), Aundrietta D. Duncan(Io Therapeutics (United States)), Jesse C. Crow(Nationwide Children's Hospital), Matthew V. Cannon(Cleveland Clinic)
Cancer Research Communications
August 25, 2025
Cited by 0


Related Papers